Product
BH006
1 clinical trial
1 indication
Indication
BioavailabilityClinical trial
An Open-label, Randomized, Single-dose, Two-period Cross-over Study to Evaluate the Relative Bioavailability Between BH006 for Injection Per the Intended Dosage Regimen and Fosaprepitant and Palonosetron in Healthy SubjectsStatus: Not yet recruiting, Estimated PCD: 2024-09-01